BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38749506)

  • 1. Exploring the impact of insufficient thermal ablation on hepatocellular carcinoma: NDST2 overexpression mechanism and its role in facilitating growth and invasion of residual cancer cells.
    Wan W; Guo D; Kang T; Pang J; Pan Y; Chen J; Liao W; Chen Y; Lin P; Li L; Yang H; He Y
    Int J Hyperthermia; 2024; 41(1):2353309. PubMed ID: 38749506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins.
    Zhang N; Li H; Qin C; Ma D; Zhao Y; Zhu W; Wang L
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):895-907. PubMed ID: 30820716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A.
    Zhou C; Chen Z; Peng C; Chen C; Li H
    Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
    Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
    EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA hsa_circ_0091579 facilitates the Warburg effect and malignancy of hepatocellular carcinoma cells via the miR-624/H3F3B axis.
    Chen Y; Song S; Zhang L; Zhang Y
    Clin Transl Oncol; 2021 Nov; 23(11):2280-2292. PubMed ID: 33934291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
    Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
    J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of PLK1 Molecule Following Incomplete Thermal Ablation Promotes the Proliferation and Invasion of Residual Hepatocellular Carcinoma.
    Kang T; Chen J; Wan W; Pang J; Wen R; Bai X; Li L; Pan Y; He Y; Yang H
    Mol Biotechnol; 2024 May; ():. PubMed ID: 38782874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
    Qiu J; Zhang S; Wang P; Wang H; Sha B; Peng H; Ju Z; Rao J; Lu L
    Cancer Med; 2020 Nov; 9(21):8159-8172. PubMed ID: 32977361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cIAP2 via NF-κB signalling affects cell proliferation and invasion in hepatocellular carcinoma.
    Jiang XJ; Chen ZW; Zhao JF; Liao CX; Cai QH; Lin J
    Life Sci; 2021 Feb; 266():118867. PubMed ID: 33310033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
    Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
    BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
    Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
    J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
    Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer.
    Pang JS; Bai XM; Wan WJ; Kang T; Wen R; Li LP; Yin HH; Lu CM; Wen DY; He Y; Yang H
    J Hepatocell Carcinoma; 2024; 11():285-304. PubMed ID: 38344425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression.
    Gao W; Chen X; Chi W; Xue M
    Int J Mol Med; 2020 Nov; 46(5):1743-1754. PubMed ID: 33000222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined inhibition of AURKA and HSF1 suppresses proliferation and promotes apoptosis in hepatocellular carcinoma by activating endoplasmic reticulum stress.
    Shen Z; Yin L; Zhou H; Ji X; Jiang C; Zhu X; He X
    Cell Oncol (Dordr); 2021 Oct; 44(5):1035-1049. PubMed ID: 34176092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression.
    Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.